PubMed Health⌕ Search

PubMed · 8145487

[Bilateral acanthamoeba keratitis].

Abstract

BACKGROUND: Given the protracted clinical course, diagnostic difficulties, frequent treatment failures and the increasing incidence, keratitis caused by free-living acanthamoeba represents a clinical challenge. PATIENT AND METHODS: A 37-year-old healthy female who wore gas-permeable contact lenses for ten years developed bilateral keratouveitis, pseudodentritic subepithelial infiltrates and corneal ring ulcers. Cultures were obtained from corneal scrapings, contact lenses and storage container. Medical treatment during the clinical course included propamidine isethionate, miconazole, ketoconazole, polymyxin B, aminoglycoside antibiotics and corticosteroids. Surgical procedures included bilateral penetrating keratoplasty and extracapsular cataract extraction. Each corneal button was examined after chemofluorescent staining with calcofluor white. RESULTS: Klebsiella oxytoca and Serratia marcescens were grown from cultures of the contact lens storage container. Although suspected early in the clinical course repeated cultures from corneal scrapings were negative for acanthamoeba. Despite transient remission, medical therapy including therapy for acanthamoeba could not halt the progression of infection in both eyes. Visual acuity deteriorated to light perception and counting fingers, respectively. Penetrating keratoplasty was performed 12 and 15 months after the onset of symptoms. Histopathological examination allowed identification of acanthamoeba cysts in each button. Because of secondary cataract formation cataract-extraction with intraocular lens implantation was simultaneously performed in the right and subsequently in the left eye. While corneal infiltrates recurred and optic atrophy developed due to secondary glaucoma in the right eye, the left corneal graft has remained clear. CONCLUSIONS: The case-report demonstrates that diagnostic procedures may fail to detect acanthamoeba organisms before obtaining a corneal button for histopathologic examination. Decreased corneal sensation later in the clinical course after initial pain disproportionately related to clinical signs does not exclude the diagnosis of an acanthamoeba keratitis. Medical treatment failure may occur despite early initiation of antiparasitic therapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F G Holz, R O Burk, H E Völcker. 1993. [Bilateral acanthamoeba keratitis].. https://doi.org/10.1055/s-2008-1045699

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis.

Acanthamoeba is an opportunistic protozoan pathogen that can cause blinding keratitis as well as fatal granulomatous encephalitis. One of the distressing aspects in combating Acanthamoeba infections is the prolonged and problematic treatment. For example, current treatment against Acanthamoeba keratitis requires early diagnosis followed by hourly topical application of a mixture of drugs that can last up to a year. The aggressive and prolonged management is due to the ability of Acanthamoeba to rapidly adapt to harsh conditions and switch phenotypes into a resistant cyst form. One possibility of improving the treatment of Acanthamoeba infections is to inhibit the ability of these parasites to switch into the cyst form. The cyst wall is partially made of cellulose. Here, we tested whether a cellulose synthesis inhibitor, 2,6-dichlorobenzonitrile (DCB), can enhance the effects of the antiamoebic drug pentamidine isethionate (PMD). Our findings revealed that DCB can block Acanthamoeba encystment and may improve the antiamoebic effects of PMD. Using in vitro assays, the findings revealed that DCB enhanced the inhibitory effects of PMD on Acanthamoeba binding to and cytotoxicity of the host cells, suggesting the cellulose biosynthesis pathway as a novel target for the improved treatment of Acanthamoeba infections.

Acanthamoeba Keratitis↗

Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome.

OBJECTIVE: To describe a newly recognized clinical syndrome in Acanthamoeba keratitis consisting of severe reactive ischemic posterior segment vascular inflammation. DESIGN: Noncomparative, retrospective, single-institution observational case series. PARTICIPANTS: Five eyes of 5 patients with Acanthamoeba keratitis. METHODS: A retrospective review of the records of patients diagnosed with Acanthamoeba keratitis between January 1, 1995, and December 1, 2005, was conducted to identify those who underwent eventual enucleation. Five enucleated eyes of 118 eyes with Acanthamoeba keratitis were identified. MAIN OUTCOME MEASURES: History, clinical examination results, available laboratory study results, and histopathologic examination results. RESULTS: Histopathologic examination showed Acanthamoeba cysts in the cornea in 4 eyes, whereas it failed to demonstrate amebic cysts or trophozoites in the posterior segment of all eyes studied and unexpectedly revealed chronic chorioretinal inflammation with perivascular lymphocytic infiltration and diffuse neuroretinal ischemia in 4 of 5 eyes. Retinal artery thrombosis was present in 3 of the 4 involved eyes, and central retinal artery and vein thrombosis was found in 1 eye. Hematologic studies in 3 patients showed abnormal anticardiolipin antibody levels in 1 patient and factor V Leiden deficiency in another. CONCLUSIONS: Prolonged Acanthamoeba keratitis can result in a severe sterile ischemic posterior segment inflammation that is potentially blinding, especially in patients with underlying hypercoagulation disorders.

Acanthamoeba Keratitis↗

Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis.

Acanthamoeba castellanii mannose-binding protein (MBP) mediates adhesion of the amoebae to corneal epithelial cells, a key first step in the pathogenesis of Acanthamoeba keratitis (AK), a devastating corneal infection. In the present study, we demonstrate that oral immunization with recombinant MBP ameliorates AK in a hamster animal model and that this protection is associated with the presence of elevated levels of anti-MBP immunoglobulin A in the tear fluid of the immunized animals.

Acanthamoeba Keratitis↗